MKI67 and neoplasm: Nuclear CARM1 expression was associated with a younger age at diagnosis; multi-center origin or multiple tumors; a higher tumor grade; a higher rate of HER2, p53, and Ki-67 expression; and a lower rate of ER and PR expression.